Table 5.
Association between the web-based integrated management program and readmission events within 2 years (N=231).
| Characteristic | Univariate | Multivariate | |||||
|
|
ORa (%) | 95% CI | P value | OR (%) | 95% CI | P value | |
| Gender: male | 1.136 | 0.548-2.356 | .73 | —b | — | — | |
| Aged over 65 years | 0.574 | 0.253-1.300 | .18 | 0.608 | 0.240 to –1.542 | .30 | |
| Type of AFc | |||||||
|
|
Persistent AF | 0.929 | 0.255-3.382 | .91 | — | — | — |
|
|
Permanent AF | 0.820 | 0.294-2.291 | .71 | — | — | — |
| mEHRAd | |||||||
|
|
mEHRA IIa | 0.444 | 0.141-1.402 | .17 | 0.378 | 0.112-1.269 | .16 |
|
|
mEHRA IIb | 0.725 | 0.225-2.340 | .59 | — | — | — |
|
|
mEHRA III | 1.754 | 0.720-4.272 | .22 | — | — | — |
| Comorbidities | |||||||
|
|
Hypertension | 1.026 | 0.462-2.280 | .95 | — | — | — |
|
|
Diabetes mellitus | 1.004 | 0.440-2.291 | .99 | — | — | — |
|
|
MIe | 0.964 | 0.206-4.509 | .96 | — | — | — |
|
|
Valvular heart disease | 1.982 | 0.947-4.416 | .07 | 2.200 | 0.994-4.870 | .05 |
|
|
Heart failure | 2.230 | 1.067-4.659 | .03 | 1.907 | 0.851-4.272 | .12 |
|
|
CADf | 1.075 | 0.508-2.275 | .85 | — | — | — |
|
|
Hyperthyroidism | 1.038 | 0.222-4.857 | .96 | — | — | — |
|
|
Cancer | 1.477 | 0.300-7.271 | .63 | — | — | — |
|
|
Dyslipidemia | 1.123 | 0.530-2.379 | .76 | — | — | — |
| Medication | |||||||
|
|
Ticlopidine hydrochloride | 0 | — | .99 | — | — | — |
|
|
Dipyridamole | 1.164 | 0.132-10.279 | .89 | — | — | — |
|
|
Aspirin | 0.343 | 0.044-2.674 | .31 | — | — | — |
|
|
Apixaban | 1.132 | 0.508-2.525 | .76 | — | — | — |
|
|
Edoxaban | 1.247 | 0.524-2.965 | .62 | — | — | — |
|
|
Clopidogrel | 4.244 | 1.131-15.927 | .03 | 4.240 | 0.843-21.324 | .08 |
|
|
Dabigatran | 0 | — | .99 | — | — | — |
|
|
Rivaroxaban | 0.693 | 0.314-1.529 | .36 | — | — | — |
| Intervention groupg | 0.428 | 0.198-0.925 | .03 | 0.406 | 0.178-0.926 | .03 | |
aOR: odds ratio.
bNot applicable.
cAF: atrial fibrillation. Reference group: Paroxysmal AF.
dmEHRA: modified European Heart Rhythm Association. Reference group: mEHRA I.
eMI: myocardial infarction.
fCAD: coronary arterial disease.
gReference group: control group.